About
Procarta Biosystems develops innovative oligonucleotide-based antimicrobial agents aimed at treating serious infections and combating antimicrobial resistance.
Explore Procarta Biosystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.